BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help
Documents 1-5 out of 5 found
  Current Search:  emadine: 46, emedastine: 23, difumarate: 10  
100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
400, ERYTHROMYCIN ETHYLSUCCINATE E.E.S., ERYTHROMYCIN ETHYLSUCCINATE EC-NAPROSYN, NAPROXEN ECONAZOLE NITRATE, ECONAZOLE NITRATE ECONOCHLOR, CHLORAMPHENICOL ECONOPRED PLUS, PREDNISOLONE ACETATE ECONOPRED, PREDNISOLONE ACETATE EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID EDETATE DISODIUM, EDETATE DISODIUM EDEX, ALPROSTADIL EDROPHONIUM CHLORIDE PRESERVATIVE FREE, EDROPHONIUM...

Matching: emadine emedastine difumarate Find similar documents More document info
100%
HTML
February Drug Approvals
Drug Approvals for February 1997 Definitions and Notes February 1997 Original New Drug Applications Original Application #: 020723 Approval Date: 27-FEB-97 Trade Name: ALDARA Chemical Type: 1 Therapeutic Potential: S Dosage Form: CREAM Applicant: 3M PHARMACEUTICALS INC Active Ingredient(s): IMIQUIMOD OTC/RX Status: RX Indication(s): Treatment of external genital and perianal warts...
Matching: emadine emedastine difumarate Find similar documents More document info
100%
HTML
Drug Approvals for December 1997
Active Ingredient(s): EMEDASTINE DIFUMARATE OTC/RX Status: RX Indication(s): For the temporary relief of the signs and symptoms of allergic conjunctivitis Original Application #: 020786 Approval Date: 24-DEC-97 Trade Name: ALLEGRA-D Chemical Type: 4 Therapeutic Potential: S Dosage Form: TABLET, EXTENDED RELEASE Applicant: HOECHST MARION ROUSSEL, INC Active Ingredient(s):...
Matching: emadine emedastine difumarate Find similar documents More document info
64%
PDF
Committee for Proprietary Medicinal Products 45th Plenary Meeting
Press Release The European Agency for the Evaluation of Medicinal products Human Medicines Evaluation Unit 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Switchboard: (+ 44- 171) 418 8400 Fax: (+ 44- 171) 418 8551 E_ Mail: mail@ emea. eudra. org http:// www. eudra. org/ emea. html 1 February 1999 CPMP/ 159/ ...

author: EMEA-CPMP subject: Press Release
Matching: emadine emedastine Find similar documents More document info

64%
PDF
Committee for Proprietary Medicinal Products 45th Plenary Meeting page 7
Press Release CPMP/ 159/ 1999 7/ 12 Clinical trials were designed to investigate the pharmacokinetic and pharmacodynamic properties of Forcaltonin in healthy volunteers, and the pharmacodynamic properties in osteoporosis patients. A secondary objective was to monitor safety and tolerability. These studies ...

author: EMEA-CPMP subject: Press Release
Matching: emadine emedastine Find similar documents More document info

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.